PIERCE ROBERT HAMILTON (Chief Scientific Officer) sold 83.3% of their position (79.79K shares) of FAETH THERAPEUTICS, INC. on the open market
Open‑market sale worth $568.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/10/2021ACC: 0001209191-21-050659
Officer· Chief Scientific Officer
Since Feb 2021
-79.79K
Net shares
Net seller
$568.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
79.79K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−6.46K
Price / share
$7.11
Trade value
$45.95K
% of position
6.7%
8/6/2021
95.82K→89.36K
Common Stock
Indirect
Shares
−6.98K
Price / share
$7.06
Trade value
$49.30K
% of position
7.8%
8/9/2021
89.36K→82.38K
Common Stock
Indirect
Shares
−66.35K
Price / share
$7.13
Trade value
$473K
% of position
80.5%
8/10/2021
82.38K→16.03K
Total
Net shares
−79.79K
Net value
-$568.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/6/2021 | S · Sale | −6.46K | $7.11 | $45.95K | 6.7% | 95.82K | 89.36K |
| Common Stock Indirect | 8/9/2021 | S · Sale | −6.98K | $7.06 | $49.30K | 7.8% | 89.36K | 82.38K |
| Common Stock Indirect | 8/10/2021 | S · Sale | −66.35K | $7.13 | $473K | 80.5% | 82.38K | 16.03K |
| Total | −79.79K | -$568.25K | ||||||
Derivative Transactions0
No derivative transactions reported